Kristin M Wall1, William Kilembe2, Bellington Vwalika3, Naw Htee Khu2, Ilene Brill4, Elwyn Chomba5, Brent A Johnson6, Lisa Haddad7, Amanda Tichacek2, Susan Allen2. 1. Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine and Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Department of Epidemiology, Rollins School of Public Health, Laney Graduate School, Emory University, Atlanta, GA, USA. Electronic address: kmwall@emory.edu. 2. Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine and Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. 3. Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine and Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Department of Gynecology and Obstetrics, School of Medicine, University of Zambia, Lusaka, Zambia. 4. Department of Epidemiology, Ryals School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA. 5. Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine and Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Ministry of Community Development, Mother and Child Health, Lusaka, Zambia. 6. Department of Biostatistics and Computational Biology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA. 7. Rwanda Zambia HIV Research Group, Department of Pathology & Laboratory Medicine, School of Medicine and Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Department of Gynecology and Obstetrics, Emory University, School of Medicine, Atlanta, GA, USA.
Abstract
OBJECTIVE: To determine the impact of hormonal contraceptive methods on risk of HIV acquisition among HIV-negative women cohabiting with HIV-positive male partners. STUDY DESIGN: From 1994-2012, HIV discordant couples recruited from a couples' voluntary HIV counseling and testing center in Lusaka, Zambia were followed longitudinally. HIV-negative partners were tested quarterly. This analysis is restricted to couples in which the man was HIV-positive and the woman was HIV-negative at enrollment and the man was not on antiretroviral treatment. Multivariate Cox models evaluated associations between time-varying contraceptive methods and HIV acquisition among women. Sensitivity analyses explored exposure misclassification and time-varying confounder mediation. RESULTS: Among 1393 couples, 252 incident infections occurred in women over 2842 couple-years (8.9 infections per 100 couple-years; 95% CI, 7.8-10.0). Multivariate Cox models indicated that neither injectable [adjusted hazard ratio (aHR)=1.2; 95% CI, 0.8-1.7], oral contraceptive pill (OCP, aHR=1.3; 95% CI, 0.9-1.8), or implant (aHR=1.1; 95% CI, 0.5-2.2) use was significantly associated with HIV acquisition relative to non-hormonal contraception controlling for woman's age, literacy and time-varying measures of genital ulceration/inflammation. This remained true when only looking at the subset of infections acquired from the spouse (82% of infections) and additionally controlling for baseline HIV viral load of the male partner, pregnancy status, and time-varying measures of sperm on a vaginal swab wet prep and self-reported unprotected sex. OCP and injectable users reported more unprotected sex (p<.001), and OCP users were more likely to have sperm on vaginal swab (p=.1) than nonhormonal method users. CONCLUSIONS: We found no association between hormonal contraception and HIV acquisition risk in women. Condom use and reinforced condom counseling should always be recommended for HIV discordant couples. HIV testing of sex partners together is critical to establish HIV risk, ascertain couple fertility intentions and counsel appropriately. IMPLICATIONS: These findings add to a controversial literature and uniquely address several common design and analytic challenges faced by previous studies. After controlling for confounders, we found no association between hormonal contraception and HIV acquisition risk in women. We support promoting condoms for HIV prevention and increasing the contraceptive method mix to decrease unintended pregnancy.
OBJECTIVE: To determine the impact of hormonal contraceptive methods on risk of HIV acquisition among HIV-negative women cohabiting with HIV-positive male partners. STUDY DESIGN: From 1994-2012, HIV discordant couples recruited from a couples' voluntary HIV counseling and testing center in Lusaka, Zambia were followed longitudinally. HIV-negative partners were tested quarterly. This analysis is restricted to couples in which the man was HIV-positive and the woman was HIV-negative at enrollment and the man was not on antiretroviral treatment. Multivariate Cox models evaluated associations between time-varying contraceptive methods and HIV acquisition among women. Sensitivity analyses explored exposure misclassification and time-varying confounder mediation. RESULTS: Among 1393 couples, 252 incident infections occurred in women over 2842 couple-years (8.9 infections per 100 couple-years; 95% CI, 7.8-10.0). Multivariate Cox models indicated that neither injectable [adjusted hazard ratio (aHR)=1.2; 95% CI, 0.8-1.7], oral contraceptive pill (OCP, aHR=1.3; 95% CI, 0.9-1.8), or implant (aHR=1.1; 95% CI, 0.5-2.2) use was significantly associated with HIV acquisition relative to non-hormonal contraception controlling for woman's age, literacy and time-varying measures of genital ulceration/inflammation. This remained true when only looking at the subset of infections acquired from the spouse (82% of infections) and additionally controlling for baseline HIV viral load of the male partner, pregnancy status, and time-varying measures of sperm on a vaginal swab wet prep and self-reported unprotected sex. OCP and injectable users reported more unprotected sex (p<.001), and OCP users were more likely to have sperm on vaginal swab (p=.1) than nonhormonal method users. CONCLUSIONS: We found no association between hormonal contraception and HIV acquisition risk in women. Condom use and reinforced condom counseling should always be recommended for HIV discordant couples. HIV testing of sex partners together is critical to establish HIV risk, ascertain couple fertility intentions and counsel appropriately. IMPLICATIONS: These findings add to a controversial literature and uniquely address several common design and analytic challenges faced by previous studies. After controlling for confounders, we found no association between hormonal contraception and HIV acquisition risk in women. We support promoting condoms for HIV prevention and increasing the contraceptive method mix to decrease unintended pregnancy.
Authors: Lisa Haddad; Kristin M Wall; Bellington Vwalika; Naw Htee Khu; Ilene Brill; William Kilembe; Rob Stephenson; Elwyn Chomba; Cheswa Vwalika; Amanda Tichacek; Susan Allen Journal: AIDS Date: 2013-10 Impact factor: 4.177
Authors: Karen E Mark; Jareen Meinzen-Derr; Rob Stephenson; Alan Haworth; Yusuf Ahmed; Dana Duncan; Andrew Westfall; Susan Allen Journal: J Womens Health (Larchmt) Date: 2007-10 Impact factor: 2.681
Authors: Debrah I Boeras; Nicole Luisi; Etienne Karita; Shila McKinney; Tyronza Sharkey; Michelle Keeling; Elwyn Chomba; Colleen Kraft; Kristin Wall; Jean Bizimana; William Kilembe; Amanda Tichacek; Angela M Caliendo; Eric Hunter; Susan Allen Journal: J Int AIDS Soc Date: 2011-04-08 Impact factor: 5.396
Authors: Wei Song; Dongning He; Ilene Brill; Rakhi Malhotra; Joseph Mulenga; Susan Allen; Eric Hunter; Jianming Tang; Richard A Kaslow Journal: PLoS One Date: 2011-08-17 Impact factor: 3.240
Authors: Kristin M Wall; Lisa Haddad; Bellington Vwalika; Naw Htee Khu; Ilene Brill; William Kilembe; Rob Stephenson; Elwyn Chomba; Cheswa Vwalika; Amanda Tichacek; Susan Allen Journal: PLoS One Date: 2013-09-30 Impact factor: 3.240
Authors: Kristin M Wall; William Kilembe; Bellington Vwalika; Lisa B Haddad; Naw Htee Khu; Ilene Brill; Udodirim Onwubiko; Elwyn Chomba; Amanda Tichacek; Susan Allen Journal: J Womens Health (Larchmt) Date: 2017-08 Impact factor: 2.681
Authors: Michelle C Sabo; Barbra A Richardson; Ludo Lavreys; Harold L Martin; Walter Jaoko; Kishorchandra Mandaliya; Jared M Baeten; Julie Overbaugh; R Scott McClelland Journal: AIDS Date: 2019-06-01 Impact factor: 4.177
Authors: Sarah Connolly; Kristin M Wall; Rachel Parker; William Kilembe; Mubiana Inambao; Ana-Maria Visoiu; Tyronza Sharkey; Eric Hunter; Susan Allen Journal: Int J STD AIDS Date: 2020-03 Impact factor: 1.359